Genmab is a biotechnology company based in Copenhagen, Denmark, that develops antibody-based medicines for the treatment of cancer and other serious diseases. Its work centres on creating human antibodies and advancing them through clinical development, often in partnership with larger pharmaceutical companies that handle later-stage development and commercialisation. The company's portfolio includes therapies used in blood cancers and other conditions, and it earns revenue through collaborations, licensing agreements and royalties on products developed from its technology.
On this site Genmab A/S appears as a stock on the Nasdaq Copenhagen (Denmark), code GMAB, with prices in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #7 of 164 on the Nasdaq Copenhagen · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Denmark yet.
TrendStrong
97/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average53.9%
From 52-week high0.0%
MomentumStrong
90/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return57.1%
6-month return75.6%
12-month, skipping last month21.8%
Stability (higher is calmer)Weak
38/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)35.5%
Worst drawdown, 1 year (smaller is calmer)-32.3%
LiquidityStrong
98/100
Trades actively.
See the numbers →
Avg daily value traded305.89M DKK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Denmark when fundamentals data for this market is added. All Denmark stocks.
52-wk range 1,512.00 – 3,060.00Daily closes, split-adjusted
Signals
50-day average2,323.66
200-day average1,946.76
Golden/death cross (60d)Golden, 47 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)96.22
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
2,653.5
Bullish
EMA 10
2,699.4
Bullish
SMA 20
2,527.6
Bullish
EMA 20
2,568.5
Bullish
SMA 50
2,323.7
Bullish
EMA 50
2,359.1
Bullish
SMA 100
2,080.1
Bullish
EMA 100
2,177.8
Bullish
SMA 200
1,946.8
Bullish
EMA 200
2,020.6
Bullish
Oscillators (daily)
RSI (14)
83.59
Bearish
MACD (12, 26)
152.5
Bullish
Momentum (12)
22.58
Bullish
Stochastic %K (14)
91.18
Bearish
Williams %R (14)
-8.82
Bearish
CCI (20)
237.6
Bearish
Pivot points (classic, last session)
S3
2,891.0
S2
2,919.0
S1
2,958.0
Pivot
2,986.0
R1
3,025.0
R2
3,053.0
R3
3,092.0
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in DKK. Educational only, not financial advice.
